Quick Answer
agilon health, inc. reported Total Revenue of $5.93 billion for fiscal year 2025.
agilon health, inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.93B -2.1% |
$6.06B +40.4% |
$4.32B +80.7% |
$2.39B +57.0% |
$1.52B +24.9% |
$1.22B +53.4% |
| Revenue (ASC 606) | $5.93B -2.1% |
$6.06B +40.4% |
$4.32B +80.7% |
$2.39B +57.0% |
$1.52B +24.9% |
$1.22B +53.4% |
| Net Income | -$391.35M -50.4% |
-$260.15M +0.9% |
-$262.60M -146.4% |
-$106.55M +73.8% |
-$406.49M -576.9% |
-$60.05M +78.7% |
| Total Assets | $1.27B -26.7% |
$1.73B -0.4% |
$1.74B +2.6% |
$1.70B +7.0% |
$1.59B +255.4% |
$446.36M |
| Cash and Equivalents | $173.71M -7.7% |
$188.23M +75.0% |
$107.57M -76.9% |
$465.30M -55.3% |
$1.04B +873.9% |
$106.80M |
| Long-Term Debt | $15.75M -54.9% |
$34.90M +8.0% |
$32.31M -16.0% |
$38.48M -11.3% |
$43.40M -32.9% |
$64.67M |
| Stockholders Equity | $126.73M -73.1% |
$470.95M -28.8% |
$661.84M -36.4% |
$1.04B -4.6% |
$1.09B +483.5% |
-$284.73M -22.7% |
| Operating Income | -$463.24M -58.6% |
-$292.13M -25.8% |
-$232.13M -120.3% |
-$105.38M +71.7% |
-$372.24M -556.8% |
-$56.67M +46.8% |
| Shares Outstanding | 414.73M +0.6% |
412.19M +1.4% |
406.39M -1.5% |
412.38M +3.1% |
400.10M +60.4% |
249.37M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.44B | -1.1% | +2.9% |
| Revenue (ASC 606) | September 30, 2025 | $1.44B | -1.1% | +2.9% |
| Net Income | September 30, 2025 | -$110.21M | +6.3% | -5.6% |
| Total Assets | September 30, 2025 | $1.60B | -23.7% | -6.8% |
| Cash and Equivalents | September 30, 2025 | $171.68M | +15.9% | +0.2% |
| Long-Term Debt | September 30, 2025 | $0.00 | -100.0% | — |
| Stockholders Equity | September 30, 2025 | $306.08M | -46.8% | -25.2% |
| Operating Income | September 30, 2025 | -$131.27M | +1.7% | -13.1% |
| Shares Outstanding | September 30, 2025 | 414.57M | +0.6% | +0.1% |
- agilon health, inc. reported Total Revenue of $5.93 billion for fiscal year 2025.
- agilon health, inc. showed a decrease of -2.1% in Total Revenue compared to the prior fiscal year.
- agilon health, inc. reported Revenue (ASC 606) of $5.93 billion for fiscal year 2025.
- agilon health, inc. showed a decrease of -2.1% in Revenue (ASC 606) compared to the prior fiscal year.
- agilon health, inc. reported Net Income of -$391.35 million for fiscal year 2025.
- agilon health, inc. showed a decrease of -50.4% in Net Income compared to the prior fiscal year.
- agilon health, inc. reported Total Assets of $1.27 billion for fiscal year 2025.
- agilon health, inc. showed a decrease of -26.7% in Total Assets compared to the prior fiscal year.
- agilon health, inc. reported Cash and Equivalents of $173.71 million for fiscal year 2025.
- agilon health, inc. showed a decrease of -7.7% in Cash and Equivalents compared to the prior fiscal year.
- agilon health, inc. reported Long-Term Debt of $15.75 million for fiscal year 2025.
- agilon health, inc. showed a decrease of -54.9% in Long-Term Debt compared to the prior fiscal year.
- agilon health, inc. reported Stockholders Equity of $126.73 million for fiscal year 2025.
- agilon health, inc. showed a decrease of -73.1% in Stockholders Equity compared to the prior fiscal year.
- agilon health, inc. reported Operating Income of -$463.24 million for fiscal year 2025.
- agilon health, inc. showed a decrease of -58.6% in Operating Income compared to the prior fiscal year.
- agilon health, inc. reported Shares Outstanding of 414.73 million shares for fiscal year 2025.
- agilon health, inc. showed an increase of +0.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: